United Capital Financial Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$410K Sell
7,534
-2,737
-27% -$133K ﹤0.01% 1224
2026
Q1
$441K Buy
10,271
+4,462
+77% +$192K ﹤0.01% 1126
2025
Q4
$255K Buy
5,809
+958
+20% +$39.6K ﹤0.01% 1234
2025
Q3
$200K Buy
4,851
+24
+0.5% +$965 ﹤0.01% 1169
2025
Q2
$213K Buy
+4,827
New +$193K ﹤0.01% 1028
2025
Q1
– Sell
-6,231
Closed -$207K – 1082
2024
Q4
$207K Buy
+6,231
New +$202K ﹤0.01% 1012
2024
Q1
– Sell
-8,741
Closed -$210K – 1097
2023
Q4
$210K Buy
+8,741
New +$190K ﹤0.01% 991

Other funds holding EXEL

United Capital Financial Advisors's EXEL Position: Q2 2026 in Review

United Capital Financial Advisors reduced its Exelixis (EXEL) stake by 27% in Q2 2026, selling an estimated $133K and leaving 7,534 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #1224.

United Capital Financial Advisors first reported a position in EXEL in Q4 2023 and has held it in 7 quarters since. The position peaked at $441K in Q1 2026. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • United Capital Financial Advisors held 7,534 shares of Exelixis worth $410K as of Q2 2026.
  • United Capital Financial Advisors sold 2,737 Exelixis shares in Q2 2026, an estimated $133K.
  • Exelixis made up ﹤0.01% of United Capital Financial Advisors's portfolio in Q2 2026, its #1224 holding.
  • United Capital Financial Advisors first reported a position in Exelixis in Q4 2023 and has held it in 7 quarters since.
  • United Capital Financial Advisors's Exelixis position peaked at $441K in Q1 2026.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.